8
Oct
2024

Samjin Pharmaceutical Co., Ltd.

Exhibitor at CPHI Milan 2024 stand 4D80, API
About Us

We, Samjin Pharmaceutical Co., Ltd. are striving to develop a drug for a healthy life and fruitful future as one of the leading companies in Korea. Since our company was founded in 1968, we have been growing up with competitive medical products and a high preference for patients. And also our R&D Center is strengthening its global competitiveness by getting an outstanding pipeline.




Main Products

API

- Clopidogrel Bisulfate (Clopidogrel Hydrogen Sulfate) (USP, EP, JP grade)

- Rosuvastatin Calcium (EP, JP grade)

...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • KR
  • 2022
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
OTC
Pharmaceutical company
Primary activities
API Producer
Pharmaceutical Company (generic finished products)
View company profile
Contact info
  • 820231400728
  • 121, Wausan-ro, Mapo-gu, 04054, Seoul, Korea, Republic Of
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 4D80, API

Products Featured at CPHI Milan 2024

  • Maciten Tablet

    Product Maciten Tablet

    1. Active Ingredient & Strength : Micronized Macitentan 10 mg 2. Indication : Pulmonary arterial hypertension (PAH) 3. Characteristics : - Dual ERA (bosentan + ambrisentan) - Long-term treatment of adult patients with PAH (WHO Group I) corresponding to WHO functional classifications II to III 4. Developm...
  • Apixaban Tablet

    Product Apixaban Tablet

    1. Active Ingredient & Strength : Apixaban 2.5 mg, 5 mg 2. Indication : Non-vitamin K antagonist oral anticoagulant (NOAC) 3. Development Status : BE test completed 4. Dossier : Elemental impurities data available
  • Dapagliflozin propanediol hydrate + Sitagliptin (Tablet)

    Product Dapagliflozin propanediol hydrate + Sitagliptin (Tablet)

    1. Active Ingredient & Strength : Dapagliflozin propanediol hydrate + Sitagliptin 100 mg/10 mg 2. Indication : Diabetes 3. Characteristics : - Simplification of 5GLT + DPP-4 co-administration - Small tablet size 4. Development Status : BE test completed
  • Tenofovir alafenamide hemifumarate

    Product Tenofovir alafenamide hemifumarate

    1. Active Ingredient & Strength : Tenofovir alafenamide Hemifumarate 25 mg 2. Indication : Hepatitis B virus (HBV) 3. Characteristics : Compared to tenofovir disoproxil fumarate, it shows high antiviral efficacy and improved renal and bone safety profile at a dose 10 times lower 4. Development Status : BE ...
  • Atorvastatin Calcium Trihydrate

    Product Atorvastatin Calcium Trihydrate

    Atorvastatin belongs to a group of medicines called statins. It is used to lower cholesterol and to reduce the risk of heart disease. Cholesterol is a fatty substance that builds up in your blood vessels and causes narrowing, which may lead to a heart attack or stroke.